Ine Skottheim Rusten

Scientific and regulatory evaluation of mechanistic <i>in silico</i> drug and disease models in drug development: Building model credibility

Flora T. Musuamba, Ine Skottheim Rusten, R Lesage et al. · CPT Pharmacometrics & Systems Pharmacology · 2021 · 133 citations · Full text

Engineering, Risk Model Validation, Verification +24

Advanced Methods for Dose and Regimen Finding During Drug Development: Summary of the EMA/EFPIA Workshop on Dose Finding (London 4–5 December 2014)

FT. Musuamba, Efthymios Manolis, Nicholas H. G. Holford et al. · CPT Pharmacometrics & Systems Pharmacology · 2017 · 67 citations · Full text

Commentary on the MID3 Good Practices Paper

Efthymios Manolis, Jacob Brogren, Susan Cole et al. · CPT Pharmacometrics & Systems Pharmacology · 2017 · 24 citations · Full text

Pharmaceutical Research, System Medicine, Simulation +19

Scientific and regulatory evaluation of empirical pharmacometric models: An application of the risk informed credibility assessment framework

Ine Skottheim Rusten, Flora T. Musuamba · CPT Pharmacometrics & Systems Pharmacology · 2021 · 18 citations · Full text

European Regulatory Perspective on Pediatric Physiologically Based Pharmacokinetic Models

Susan Cole, Justin L. Hay, Elisa Luzon et al. · International Journal of Pharmacokinetics · 2017 · 12 citations

Drug Safety, Translational Medicine, Physiologically Based Pharmacokinetics +11